• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Ensuring Widespread and Equitable Access to Treatments for COVID-19.

作者信息

Vasan Ashwin, Foote Mary, Long Theodore

机构信息

New York City Department of Health and Mental Hygiene, Long Island City, New York.

Mailman School of Public Health and Vagelos College of Physicians and Surgeons, Columbia University, New York, New York.

出版信息

JAMA. 2022 Aug 23;328(8):705-706. doi: 10.1001/jama.2022.13554.

DOI:10.1001/jama.2022.13554
PMID:35904777
Abstract
摘要

相似文献

1
Ensuring Widespread and Equitable Access to Treatments for COVID-19.确保广泛且公平地获得新冠病毒病治疗方法。
JAMA. 2022 Aug 23;328(8):705-706. doi: 10.1001/jama.2022.13554.
2
Telehealth in COVID-19 and Cardiovascular Disease-Ensuring Equitable Care.COVID-19与心血管疾病中的远程医疗——确保公平医疗
Ann Acad Med Singap. 2020 Nov;49(11):902-904. doi: 10.47102/annals-acadmedsg.2020338.
3
Access to novel therapies for COVID-19 - distributive justice and Russian roulette?获得针对COVID-19的新型疗法——分配正义与俄罗斯轮盘赌？
S Afr Med J. 2020 Oct 13;110(12):1156-1157. doi: 10.7196/SAMJ.2020.v110i12.15362.
4
Ensuring equitable access to COVID-19 vaccines.确保公平获得 COVID-19 疫苗。
Bull World Health Organ. 2020 Dec 1;98(12):826-827. doi: 10.2471/BLT.20.021220.
5
In September 2020, the World Health Organization called for 'equitable access to COVID-19 tools' which included 'the development, production and equitable access to COVID-19 tests, treatments and vaccines globally, while strengthening health systems'. What evidence is there of inequity of access so far in this pandemic? What is the role of national governments and of the WHO in this?2020年9月，世界卫生组织呼吁“公平获取新冠病毒工具”，其中包括“在全球范围内研发、生产并公平获取新冠病毒检测手段、治疗方法和疫苗，同时加强卫生系统”。在这场大流行中，到目前为止有哪些获取方面不公平的证据？各国政府和世界卫生组织在此过程中分别扮演什么角色？
Med Confl Surviv. 2021 Sep;37(3):187-196. doi: 10.1080/13623699.2021.1969879.
6
In September 2020, the World Health Organization called for 'equitable access to COVID-19 tools' which included 'the development, production and equitable access to COVID-19 tests, treatments and vaccines globally, while strengthening health systems'. What evidence is there of inequity of access so far in this pandemic? What is the role of national governments and of the WHO in this?2020年9月，世界卫生组织呼吁“公平获取新冠疫情相关工具”，其中包括“在全球范围内研发、生产并公平获取新冠病毒检测手段、治疗方法和疫苗，同时加强卫生系统”。在这场大流行中，到目前为止有哪些获取方面不公平的证据？各国政府和世卫组织在此过程中分别扮演什么角色？
Med Confl Surviv. 2021 Sep;37(3):197-204. doi: 10.1080/13623699.2021.1969878. Epub 2021 Aug 25.
7
Health Disparities and the Coronavirus Disease 2019 (COVID-19) Pandemic in the USA.美国的健康差异与2019冠状病毒病（COVID-19）大流行
J Gen Intern Med. 2020 Aug;35(8):2431-2432. doi: 10.1007/s11606-020-05916-w. Epub 2020 May 27.
8
Time to deliver: accelerating more equitable access to better quality primary health-care services in the WHO South-East Asia Region.交付时间：在世卫组织东南亚区域加快更公平地获得更高质量的初级卫生保健服务。
WHO South East Asia J Public Health. 2019 Apr;8(1):1-3. doi: 10.4103/2224-3151.255341.
9
Covid-19: ensuring equality of access to testing for ethnic minorities.新冠疫情：确保少数族裔在检测方面享有平等机会。
BMJ. 2020 May 29;369:m2122. doi: 10.1136/bmj.m2122.
10
Disparities in COVID-19 Outcomes: Understanding the Root Causes Is Key to Achieving Equity.新冠疫情结果的差异：理解根本原因是实现公平的关键。
J Public Health Manag Pract. 2021 Jan/Feb;27 Suppl 1, COVID-19 and Public Health: Looking Back, Moving Forward:S63-S65. doi: 10.1097/PHH.0000000000001272.

引用本文的文献

1
Optimal timing of nirmatrelvir/ritonavir treatment after COVID-19 symptom onset or diagnosis: target trial emulation.奈玛特韦/利托那韦治疗 COVID-19 症状出现或确诊后的最佳时机：目标试验模拟。
Nat Commun. 2023 Dec 16;14(1):8377. doi: 10.1038/s41467-023-43706-0.
2
Retrospective analysis of equity-based optimization for COVID-19 vaccine allocation.基于公平性的新冠疫苗分配优化回顾性分析
PNAS Nexus. 2023 Sep 9;2(9):pgad283. doi: 10.1093/pnasnexus/pgad283. eCollection 2023 Sep.
3
Understanding the Relationship Between Antiviral Prescription Data and COVID-19 Incidence in New York City: A Retrospective Cohort Study.
了解纽约市抗病毒药物处方数据与新冠病毒感染率之间的关系：一项回顾性队列研究。
Open Forum Infect Dis. 2023 May 21;10(6):ofad281. doi: 10.1093/ofid/ofad281. eCollection 2023 Jun.
4
Retrospective Analysis of Equity-Based Optimization for COVID-19 Vaccine Allocation.基于公平性的新冠疫苗分配优化的回顾性分析
medRxiv. 2023 May 11:2023.05.08.23289679. doi: 10.1101/2023.05.08.23289679.
5
Population-Level Strategies for Nirmatrelvir/Ritonavir Prescribing-A Cost-effectiveness Analysis.奈玛特韦/利托那韦处方的人群水平策略——成本效益分析
Open Forum Infect Dis. 2022 Nov 25;9(12):ofac637. doi: 10.1093/ofid/ofac637. eCollection 2022 Dec.